Predictors of Lipid Profile Abnormalities Among Patients with Metabolic Syndrome in Southwest Ethiopia: A Cross-Sectional Study

References

• Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(12):1–8. doi:10.1007/s11906-018-0812-z
   PubMedGoogle Scholar
• Jahangiry L, Khosravi-far L, Sarbakhsh P, Kousha A, Entezar Mahdi R, Ponnet K. Prevalence of metabolic syndrome and its determinants among Iranian adults: evidence of IraPEN survey on a bi-ethnic population. Sci Rep. 2019;9(1):1–7. doi:10.1038/s41598-019-44486-8
   PubMedGoogle Scholar
• Sergio LF, Sandra S. Metabolic syndrome and associated factors in adults of the Amazon region. PLoS One. 2016;11(12):1–14.
   Google Scholar
• Osei-Yeboah J, Owiredu WKBA, Norgbe GK, et al. The prevalence of metabolic syndrome and its components among people with type 2 diabetes in the Ho municipality, Ghana: a Cross-Sectional Study. Int J Chronic Dis. 2017;2017:8765804. doi:10.1155/2017/8765804
   PubMedGoogle Scholar
• Elizabeth H, Herningtyas TSN. Prevalence and distribution of metabolic syndrome and its components among provinces and ethnic groups in Indonesia. BMC Public Health. 2019;19:1–12.
   PubMed Web of Science ®Google Scholar
• Samrawit SWM. Disease burden and associated risk factors for metabolic syndrome among adults in Ethiopia. BMC Cardiovasc Disord. 2019;19(236):1–8.
   PubMedGoogle Scholar
• Tran A, Gelaye B, Girma B, et al. Prevalence of metabolic syndrome among working adults in Ethiopia. Int J Hypertens. 2011;2011:193719. doi:10.4061/2011/193719
   PubMedGoogle Scholar
• Gebremeskel GG, Berhe KK, Belay DS, Kidanu BH. The magnitude of metabolic syndrome and its associated factors among patients with type 2 diabetes mellitus in Ayder Comprehensive Specialized Hospital, Tigray, Ethiopia: a Cross-Sectional Study. BMC Res Notes. 2019;12(603):1–7. doi:10.1186/s13104-019-4609-1
   PubMedGoogle Scholar
• Halpern A, Mancini MC, Magalhães MEC, et al. Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment. Diabetol Metab Syndr. 2010;2(55):1–20. doi:10.1186/1758-5996-2-55
   PubMedGoogle Scholar
• Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis. 2017;11(8):215–225. doi:10.1177/1753944717711379
   PubMedGoogle Scholar
• Mccracken E, Monaghan M, Sreenivasan S. Pathophysiology of the metabolic syndrome. Clin Dermatol. 2018;36(1):14–20. doi:10.1016/j.clindermatol.2017.09.004
   PubMed Web of Science ®Google Scholar
• Lee M, Han K, Kim MK, Koh ES, Kim ES. Changes in metabolic syndrome and its components and the risk of type 2 diabetes: a Nationwide Cohort Study. Sci Rep. 2020;10:1–8.
   PubMedGoogle Scholar
• Henry N, Ginsberg PRM. The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus. J Cardiometab Syndr. 2010;4(2):113–119.
   Google Scholar
• Anwar A, Devi G, Hospita C, Hanif A. metabolic syndrome; frequency in patients presented with ischemic heart disease. Prof Med J. 2018;25(2):277–281.
   Google Scholar
• Mani P, Ren H, Neeland IJ, et al. The association between HDL particle concentration and incident metabolic syndrome in the Multi-Ethnic Dallas Heart Study. Diabetes Metab Syndr. 2018;11(1):1–13.
   Google Scholar
• Devi SA, Jyothi B. Dyslipidemia in metabolic syndrome: an overview of lipoprotein- related disorders. Int J Cardiol Lipidol Res. 2017;4(1):6–15. doi:10.15379/2410-2822.2017.04.01.02
   Google Scholar
• Natah TM, Mohammed AK. Lipid abnormalities in metabolic syndrome patients. Adv Nat Appl Sci. 2014;8(13):25–29.
   Google Scholar
• Alipour N, Wong ND, Malik S. The metabolic syndrome and dyslipidemia in primary and secondary prevention: examining the implications of recent trials The metabolic syndrome and dyslipidemia in primary and secondary prevention: examining the implications of recent trials. Clin Lipidol. 2012;7(2):223–239. doi:10.2217/clp.12.13
   Web of Science ®Google Scholar
• Nolan PB, Carrick-Ranson G, Stinear JW, Reading SA, Dalleck LC. Prevalence of metabolic syndrome and metabolic syndrome components in young adults: a pooled analysis. Prev Med Rep. 2017;7:211–215. doi:10.1016/j.pmedr.2017.07.004
   PubMedGoogle Scholar
• Blaton VH, Korita I, Bulo A. How is a metabolic syndrome related to dyslipidemia? Biochem Med. 2008;18(1):14–24. doi:10.11613/BM.2008.003
   Web of Science ®Google Scholar
• Kolovou G, Cardiac O, Anagnostopoulou KK. Pathophysiology of dyslipidemia in the metabolic syndrome. Postgrad Med J. 2005;81(956):358–366. doi:10.1136/pgmj.2004.025601
   PubMed Web of Science ®Google Scholar
• Ruotolo G, Howard BV. Dyslipidemia of the metabolic syndrome. Cardiol Rep. 2002;4(6):494–500. doi:10.1007/s11886-002-0113-6
   PubMedGoogle Scholar
• National Cholesterol Education Program. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). 2001.
   Google Scholar
• World health organization. International Guide for Monitoring Alcohol Consumption. 2000.
   Google Scholar
• Caspersen CJ, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep. 1985;100(2):126.
   PubMed Web of Science ®Google Scholar
• Fiorentino M, Landais E, Bastard G, Carriquiry A, Wieringa FT, Berger J. Urban school children, and adolescents: results from two 24 h recalls in state primary schools in Dakar. Nutrients. 2016;8(10):1–17. doi:10.3390/nu8100650
   Web of Science ®Google Scholar
• Shiferaw B, Tagesech Y, Mohammed AE. Dyslipidemia and associated factors among diabetic patients attending Durame General Hospital in Southern Nations, Nationalities, and People’s Region. Diabetes Metab Syndr Obes Targets Ther. 2017;10:265–271. doi:10.2147/DMSO.S135064
   PubMedGoogle Scholar
• Solomon T, Alemseged F. Risk factors for cardiovascular diseases among diabetic patients in southwest Ethiopia. Ethiop J Health Sci. 2010;20(2):122–128.
   Google Scholar
• Victor S, Lydia K, Jemimah K, Drusilla M. Prevalence of dyslipidemia and the associated factors among type 2 diabetes patients in Turbo Sub- County, Kenya. J Endocrinol Diabetes. 2017;4(5):1–9. doi:10.15226/2374-6890/4/5/00190
   Google Scholar
• Bello-ovosi BO, Ovosi JO, Ogunsina MA, Asuke S, Ibrahim MS. Prevalence and pattern of dyslipidemia in patients with type 2 diabetes mellitus in Zaria, Northwestern Nigeria. Pan Afr Med J. 2019;34(123):1–9. doi:10.11604/pamj.2019.34.123.18717
   PubMedGoogle Scholar
• Mohammadbeigi A, Farahani H, Moshiri E, Sajadi M, Ahmadli R. Prevalence of metabolic syndrome and associations with lipid profiles in Iranian men: a population-based screening program. World J Mens Health. 2018;36(1):50–56. doi:10.5534/wjmh.17014
   PubMedGoogle Scholar
• Yang Z, Ding X, Liu J, Duan P, Si L, Binghua Wan PT. Associations between anthropometric parameters and lipid profiles in Chinese individuals with age >40 years and BMI < 28kg/m 2. PLoS One. 2017;12(6):1–11.
   Web of Science ®Google Scholar
• Singh O, Gupta M, Khajuria V. lipid profile and its relationship with blood glucose levels in. Natl J Physiol Pharm Pharmacol. 2015;5(2):134–137. doi:10.5455/njppp.2015.5.051120141
   Google Scholar
• Cláudia MS, Claudileide SS, Edvânia CA, Ilma Kruze GA, Alcides D. Lipid and glucose profiles in outpatients and their correlation with anthropometric indices. Port J Cardiol. 2013;32(1):35–41.
   Google Scholar
• Nazaimoon W, Mohamud W, Ismail A, Sharifuddin A. Prevalence of metabolic syndrome and its risk factors in adult Malaysians: results of a nationwide survey. Diabetes Res Clin Pract. 2012;96(1):91–97. doi:10.1016/j.diabres.2011.11.020
   PubMedGoogle Scholar
• Wong-Mcclure RA, Gregg EW, Barceló A, et al. Prevalence of metabolic syndrome in Central America: a Cross-Sectional Population-Based Study. Rev Panam Salud Publ. 2015;38(3):202–208.
   PubMedGoogle Scholar
• Belete B, Biadgo B, Melak T, et al. The prevalence of metabolic syndrome and its components among type 2 diabetes mellitus patients at a Tertiary Hospital, Northwest Ethiopia. Ethiop J Health Sci. 2018;28(5):645–654.
   PubMedGoogle Scholar
• Tadewos A, Ambachew H, Assegu D. Pattern of metabolic syndrome in relation to gender among type-II DM patients in Hawassa University Comprehensive Specialized Hospital, Hawassa, Southern Ethiopia. Health Sci J. 2017;11(3):1–8.
   Google Scholar
• Camilla Ribeiro LF, Carla Campos MM, Ivelisse Fhrideraid Alves FC, Mônica Oliveira C, Simões MODS, Carvalho DFD. Persistent metabolic syndrome and risk of cardiovascular disease in children and adolescents. Rev Bras Enferm. 2018;71(3):1013–1021. doi:10.1590/0034-7167-2016-0564
   PubMedGoogle Scholar
• Sison O, Castillo-Carandang N, Ladia MA, et al. Prevalence of metabolic syndrome and cardiovascular risk factors among community health workers in selected villages in the Philippines. J ASEAN Fed Endocr Soc. 2019;34(2):171–179.
   PubMedGoogle Scholar
• Dhoj TS, Raj KCS, Santosh G, Deepika G. Dyslipidemia in type 2 diabetes mellitus. J Pathol Nepal. 2017;7:1149–1154. doi:10.3126/jpn.v7i2.17978
   Google Scholar
• Gebreyes YF, Goshu DY, Geletew TK, et al. Prevalence of high blood pressure, hyperglycemia, dyslipidemia, metabolic syndrome and their determinants in Ethiopia: evidence from the national NCDs STEPS. PLoS One. 2018;13(5):1–18. doi:10.1371/journal.pone.0194819
   Google Scholar
• Qi L, Ding X, Tang W, Li Q, Mao D, Wang Y. Prevalence and risk factors associated with dyslipidemia in Chongqing, China. Int J Environ Res Public Health. 2015;60(10):13455–13465. doi:10.3390/ijerph121013455
   Google Scholar
• Bekele GE, Thupayagale-tshweneagae G. Prevalence and associated factors of metabolic syndrome and its individual components among adolescents. Int J Public Health Sci. 2020;9(1):46–56.
   Google Scholar
• Wube TB, Begashaw TA, Hirigo AT. Prevalence of dyslipidemia and its correlation with anthropometric and blood pressure variables among type-2 diabetic patients. J Diabetes Endocrinol. 2020;11(1):10–17. doi:10.5897/JDE2019.0132
   Google Scholar
• Pokharel DR, Khadka D, Sigdel M, et al. Prevalence and pattern of dyslipidemia in Nepalese individuals with type 2 diabetes. BMC Res Notes. 2017;10(1):1–11. doi:10.1186/s13104-017-2465-4
   PubMedGoogle Scholar
• Narindrarangkura P, Bosl W, Rangsin R, Hatthachote P. Prevalence of dyslipidemia associated with complications in diabetic patients: a nationwide study in Thailand. BMC Lipids Health Dis. 2019;3:1–8.
   Google Scholar